Clinical Trial Update: Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

View source ↗

Summary

This clinical trial update reports the performance of AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, in US patients newly referred to mem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Frontotemporal Dementia
• Mixed Dementia
• Parkinson Disease Dementia
• Progressive Aphasia
• Vascular Dementia

Snippet

Sponsor: Exonhit | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Status: COMPLETED